Chemical Compound

Canertinib

CAS Registry Number 267243-28-7
Back to search Request a Quote
Canertinib chemical structure
Primary Record

Canertinib

In stock
5,844 g
Purity
99.2 %
CAS
267243-28-7

Compound Identifiers & Properties

CAS
267243-28-7
PubChem CID
156414
SMILES
C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
Canonical SMILES
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1

Names & Synonyms

  • Canertinib
  • 267243-28-7
  • canertinibum
  • Alumina
  • Canertinib free base
  • Canertinib HCl
  • Canertinib (CI-1033)
  • Canertinib [INN]
  • CI-1033
  • Canertinib dihydrochloride
  • canertinibumcanertinib
  • CANETINIB
  • C24H25ClFN5O3
  • Canertinib [INN:BAN]
  • CI-1033(Canertinib)
  • C78W1K5ASF
  • DISCONTINUED""
  • Canertinib (CI1033
  • A1CEA
  • CANERTINIB [MI]
  • UNII-C78W1K5ASF
  • RefChem:917970
  • Canertinib, CI 1033
  • Caneritinib; CI-1033
  • PD-183805
  • DTXSID8048943
  • CHEMBL31965
  • D0YB3W
  • Canertinib - CI-1033
  • CI-1033 (Canertinib)
  • AC1L4G5R
  • CANERTINIB [WHO-DD]
  • MFCD09837878
  • SCHEMBL54837
  • DTXCID1028869
  • cc-178
  • CHEBI:61399
  • MLS004774146
  • PD 183805 dihydrochloride
  • BDBM4779
  • CHEMBL545315
  • cid_156414
  • GTPL5675
  • orb1301044
  • SCHEMBL29368458
  • SCHEMBL29623482
  • SCHEMBL29655741
  • CTK8E6872
  • KS-00000XPE
  • 267243-28-7 (free base)
  • AOB6938
  • EX-A078
  • QCR-127
  • SYN1030
  • Canertinib dihydrochloride (USAN)
  • Canertinib dihydrochloride [USAN]
  • CI1033
  • OMZCMEYTWSXEPZ-UHFFFAOYSA-N
  • BCPP000301
  • BS181
  • GLXC-05819
  • HMS3244M17
  • HMS3244M18
  • HMS3244N17
  • BCP01790
  • CI 1033
  • C24-H25-Cl-F-N5-O3
  • Tox21_113361
  • ABP000862
  • AN-562
  • CID156414
  • EBC-13032
  • NCGC00182713-01
  • NSC780019
  • NSC801011
  • s1019
  • ZINC27439698
  • PD183805
  • AKOS005145818
  • ACN-041314
  • BCP9000481
  • BCP9000482
  • BCP9000525
  • CCG-269588
  • CS-0121
  • DB05424
  • NSC-780019
  • NSC-801011
  • RL02901
  • SB16594
  • SDCCGSBI-0654262.P002
  • CI-1033(Canertinib)/PD-183805
  • NCGC00182713-02
  • NCGC00182713-07
  • NCGC00182713-18
  • AK468685
  • AS-56189
  • AT-17081
  • BC256329
  • HY-10367
  • SC-22834
  • SMR003500789
  • SN-26606
  • N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide
  • AB0035841
  • PD 183805
  • PD0183805
  • RT-011909
  • 2204B
  • A1845
  • CAS-267243-28-7
  • FT-0654215
  • N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
  • NS00071801
  • PD-0183805
  • Y0252
  • 289499-45-2
  • EC-000.2258
  • J1.314.856B
  • A10211
  • A25038
  • N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide
  • Z-3276
  • 32335-EP2281815A1
  • 32335-EP2292615A1
  • 32335-EP2301933A1
  • 32335-EP2305640A2
  • 32335-EP2305671A1
  • 32335-EP2311827A1
  • EN300-6493001
  • 499C452
  • N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide
  • N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
  • I06-1255
  • I14-8433
  • Q5032274
  • BRD-K50168500-001-07-9
  • Canertinib, PD-183805, CI1033, PD183805
  • Z166624030
  • N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide
  • 2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-
  • 4-(3-Chloro-4-fluoroanilino)-6-(acryloylamino)-7-(3-morpholinopropoxy)quinazoline
  • 6-acrylamido-N-(3-chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazolin-4-amine
  • n-(4-(3-chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide
  • N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide
  • N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholinopropoxy)-6-quinazolinyl]propeneamide
  • N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholinopropoxy)quinazoline-6-yl]acrylamide
  • 2-Propenamide, N-(4-((3-chloro-4-fluorophenyl) amino)-7-(3-(4-morpholinyl) propoxy)-6-quinazolinyl)-, dihydrochloride
  • 2-Propenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-morpholinyl)propoxy)-6-quinazolinyl)-, dihydrochloride
  • 2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-
  • CI-1033|||N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide
  • N-(4-(3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-MORPHOLIN-4-YL)PROPOXY)QUINAZOLIN-6-YL)PROP-2-ENAMIDE
  • N-(4-(3-chloro-4-fluorophenyl)amino)-7-(3-morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride
  • N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide
  • N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride
  • N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride
  • N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide
  • N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride
  • N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide; N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide;
  • N-{4-(3-Chloro-4-fluoroanilino)-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide